Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism

Related Experiment Videos

J Raza1, P C Hindmarsh, C G Brook

  • 1London Centre for Paediatric Endocrinology, Great Ormond Street, Hospital for Children, London.

Insights

Thyroid hormone replacement therapy in infants with hypothyroidism is effective. The study found that initial thyroid stimulating hormone (TSH) levels and the cause of hypothyroidism did not impact the rate of TSH normalization.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Care
  • Thyroid Disorders

Background:

  • Congenital hypothyroidism requires timely treatment to prevent developmental issues.
  • Thyroid stimulating hormone (TSH) levels are a key indicator of thyroid function and treatment efficacy.
  • Understanding factors influencing TSH normalization can optimize infant hypothyroidism management.

Purpose of the Study:

  • To investigate the rate of serum TSH concentration decline in hypothyroid infants treated with thyroxine.
  • To determine if initial TSH levels or the etiology of hypothyroidism affect the speed of TSH normalization.

Main Methods:

  • Prospective study of 32 hypothyroid infants (11 boys, 21 girls) treated with thyroxine (100 µg/m²/24 hours).
  • Serum TSH levels were monitored longitudinally post-treatment initiation.
  • Etiology of hypothyroidism was assessed using isotope scans in 27 patients (athyrotic, ectopic gland, dyshormonogenesis).

Main Results:

  • Serum TSH remained elevated at 3 months (81%), 6 months (62.5%), and 1 year (28%) in a significant proportion of infants.
  • The mean age for achieving normal serum TSH was 0.79 years.
  • Neither the diagnosis of hypothyroidism nor initial TSH concentrations influenced the rate of TSH decline.

Conclusions:

  • Thyroxine treatment leads to a gradual normalization of TSH in infants with hypothyroidism.
  • The specific cause of congenital hypothyroidism and initial TSH levels do not appear to significantly alter the time course of TSH normalization.
  • Continued monitoring is essential to confirm TSH normalization in treated infants.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...